GDK Biotech released its performance for the first three quarters, with a net loss attributable to the parent company of 86.47 million yuan
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, GDK Biotech disclosed its third-quarter report for 2025. The company achieved revenue of 74.66 million yuan in the first three quarters, a year-on-year increase of 91.93%; the net profit attributable to shareholders was a loss of 86.47 million yuan; the net profit excluding non-recurring gains and losses was a loss of 91.11 million yuan; basic earnings per share were -0.70 yuan
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments